TCL Archive FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC. March 30, 2001
TCL Archive Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million June 21, 1974
TCL Archive Fisher Unable To Answer Key Questions, Blames NCI, A Second Hearing On NSABP June 24, 1994
TCL Archive NCI Has Congressional Mandate Fr Planning Clinical Trials of Unconventional Therapies, Chabner Says June 5, 1992
TCL Archive Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer February 25, 2011
